Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study.

导出原文传递

翻译打印收藏纠错

作者： Sanjay Kewalchand,Lalwani ^[1] ; Padmasani Venkat,Ramanan ^[2] ; Amita,Sapru ^[3] ; Balasubramanian,Sundaram ^[4] ; Bela Hasmukh,Shah ^[5] ; Dinesh,Kaul ^[6] ; N,Karthik Nagesh ^[7] ; Warren V,Kalina ^[8] ; Rohit,Chand ^[9] ; Meichun,Ding ^[8] ; Suresh,Suroju ^[10] ; Daniel A,Scott ^[11] ; Stephen P,Lockhart ^[12]

作者单位： Department of Pediatrics, Bharati Vidyapeeth Medical College and Hospital, Pune, Maharashtra, India. ^[1] Department of Pediatrics, Sri Ramachandra Hospital, Chennai, Tamil Nadu, India. ^[2] Department of Pediatrics, KEM Hospital Research Centre, Pune, Maharashtra, India. ^[3] Department of Pediatrics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, Tamil Nadu, India. ^[4] Department of Pediatrics, B.J. Medical College and Civil Hospital, Ahmedabad, Gujarat, India. ^[5] Department of Pediatrics, Sir Ganga Ram Hospital, New Delhi, India. ^[6] Department of Pediatrics, Manipal Hospital, Bengaluru, Karnataka, India. ^[7] Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA. ^[8] Global Site and Study Operations, Pfizer Ltd, Mumbai, India. ^[9] Vaccine Clinical Research and Development, Pfizer Ltd, Hurley, UK. ^[10] Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA. ^[11] Vaccine Clinical Research and Development, Pfizer Ltd, Hurley, UK. Electronic address: stephen.p.lockhart@pfizer.com. ^[12]

关键词 Children Clinical trial Infant Multidose Pneumococcal conjugate Vaccine